Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Byers

Showing results (231-240 of 234) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 234 results.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 9, 2010
Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysisBarry I Freedman, Rajeev N Shenoy, Jonathan A Planer, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979
The selection and evaluation of new chelating agents for the treatment of iron overloadC G Pitt, G Gupta, W E Estes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 21, 2011
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patientsBarry I Freedman, Lilian Andries, Zak K Shihabi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1Barry I Freedman, Carl D Langefeld, Kelly K Andringa, et al.
Pageof 24

Showing results (231-240 of 234) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 234 results.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 9, 2010
Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysisBarry I Freedman, Rajeev N Shenoy, Jonathan A Planer, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979
The selection and evaluation of new chelating agents for the treatment of iron overloadC G Pitt, G Gupta, W E Estes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 21, 2011
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patientsBarry I Freedman, Lilian Andries, Zak K Shihabi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1Barry I Freedman, Carl D Langefeld, Kelly K Andringa, et al.
Pageof 24